Jacobs Bruce N. Insider Trades

Insider Trading History

Track insider trading activity for Jacobs Bruce N.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$902k 12,653 shares
$71.29
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $19.1M 260,241 shares
Last Trade
Jun 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$902k 12,653 shares
$71.29
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $926k 12,653 shares
Last Trade
May 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.2M 15,000 shares
$79.67
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $18.1M 247,588 shares
Last Trade
May 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.2M 15,000 shares
$79.67
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $17.4M 236,991 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$417k 4,895 shares
$85.29
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $17.9M 245,059 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.77M 52,950 shares
$90.10
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $17.8M 243,020 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$674k 7,576 shares
$88.93
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $22.4M 306,629 shares
Last Trade
Sep 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.81M 79,220 shares
$48.12
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $2.02M 27,653 shares
Last Trade
Sep 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.81M 79,220 shares
$48.12
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $16.6M 227,409 shares
Last Trade
Sep 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.96M 79,220 shares
$50.00
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $5.12M 69,899 shares
Last Trade
Mar 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$684k 25,000 shares
$27.37
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $16.6M 226,886 shares
Last Trade
Mar 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$684k 25,000 shares
$27.37
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $14.9M 203,167 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$214k 7,035 shares
$30.45
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $15.3M 208,921 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81M 60,000 shares
$30.17
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $6.95M 94,899 shares
Last Trade
Jan 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$382k 10,000 shares
$38.17
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $13.1M 178,921 shares
Last Trade
Jan 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$382k 10,000 shares
$38.17
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $7.68M 104,899 shares
Last Trade
Jun 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$756k 25,000 shares
$30.22
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $12.3M 168,554 shares
Last Trade
Jun 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$756k 25,000 shares
$30.22
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $10.5M 143,907 shares
Last Trade
Mar 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$165k 3,934 shares
$41.85
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Financial Officer
Holding Value $13.7M 187,500 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.16M 187,500 shares
$43.50
$73.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up